The blockbuster drug era is over, and drug manufacturers are now striving for a more diversified portfolio. With a newer toolbox of options to intensify downstream manufacturing operations, it is important to understand what factors should impact decisions regarding the implementation of these solutions.
Although single-use technologies are widely adopted in upstream production processes, what is necessary to transition them to downstream manufacturing scale? Explore strategies for meeting the ever-increasing upstream titers and volumes to prevent purification from becoming a bottleneck.
Discover a platform that simplifies column handling at all scales from process development to full-scale production in GMP environments with intelligent packing, intuitive handling, and predictable scale-up.
Learn about a bench-top chromatography system well-suited for both GMP and non-GMP work, designed to simplify operations from column packing to scale up and technology transfer.
Find out about a single-use liquid chromatography system that offers the performance and documentation required for use in a GMP-regulated environment.
Read about an automated liquid chromatography system built for process scale-up and large-scale biopharmaceutical manufacturing that provides over a million possible configurations.